J. Simons

发表

Successful reintroduction of statin therapy after statin-associated rhabdomyolysis.

A. Holbrook, A. Don-Wauchope, J. Simons, 2015, Journal of clinical lipidology.

Evaluation of natriuretic peptide recommendations in heart failure clinical practice guidelines.

A. Don-Wauchope, J. Simons, 2016, Clinical biochemistry.

Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, medRxiv.

People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, The Journal of infectious diseases.

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

G. Umviligihozo, P. Sereda, S. Datwani, 2022, medRxiv.

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, The Journal of infectious diseases.

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, npj Vaccines.

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

J. Montaner, M. DeMarco, G. Umviligihozo, 2021, medRxiv : the preprint server for health sciences.

Diagnostic accuracy of RT-PCR for detection of SARS-CoV-2 compared to a composite reference standard in hospitalized patients

A. Stefanović, I. Sekirov, C. Lowe, 2021, medRxiv.

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

J. Montaner, G. Umviligihozo, M. Niikura, 2021, medRxiv.

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine

J. Montaner, M. DeMarco, M. Niikura, 2023, Open forum infectious diseases.

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine

J. Montaner, M. DeMarco, M. Niikura, 2023, Open forum infectious diseases.

Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, medRxiv.

SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy

Richard H. Liang, M. Niikura, Z. Brumme, 2023, AIDS.

Rates of inappropriate laboratory test utilization in Ontario.

A. Don-Wauchope, A. Sweetman, N. Chami, 2017, Clinical biochemistry.

Matrix and bilirubin interference for high-sensitivity cardiac troponin I.

P. Kavsak, L. Clark, J. Simons, 2015, Clinica chimica acta; international journal of clinical chemistry.

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia

M. Morshed, I. Sekirov, P. Levett, 2021, Journal of Clinical Virology.

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, AIDS.

Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults

Richard H. Liang, J. Montaner, M. DeMarco, 2023, medRxiv.

Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, Frontiers in Immunology.